Logo image of RDFN

REDFIN CORP (RDFN) Stock Fundamental Analysis

NASDAQ:RDFN - Nasdaq - US75737F1084 - Common Stock - Currency: USD

11.19  -0.04 (-0.36%)

After market: 11.2994 +0.11 (+0.98%)

Fundamental Rating

2

RDFN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. RDFN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RDFN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RDFN has reported negative net income.
RDFN had a positive operating cash flow in the past year.
In the past 5 years RDFN always reported negative net income.
In multiple years RDFN reported negative operating cash flow during the last 5 years.
RDFN Yearly Net Income VS EBIT VS OCF VS FCFRDFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

With a Return On Assets value of -17.78%, RDFN is not doing good in the industry: 70.77% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.78%
ROE N/A
ROIC N/A
ROA(3y)-16.08%
ROA(5y)-11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDFN Yearly ROA, ROE, ROICRDFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200 -300

1.3 Margins

The Gross Margin of RDFN (35.05%) is better than 63.08% of its industry peers.
RDFN's Gross Margin has improved in the last couple of years.
RDFN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.46%
GM growth 5Y13.57%
RDFN Yearly Profit, Operating, Gross MarginsRDFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

RDFN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDFN has more shares outstanding
RDFN has more shares outstanding than it did 5 years ago.
RDFN has a worse debt/assets ratio than last year.
RDFN Yearly Shares OutstandingRDFN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RDFN Yearly Total Debt VS Total AssetsRDFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

RDFN has an Altman-Z score of -0.12. This is a bad value and indicates that RDFN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.12, RDFN is doing worse than 69.23% of the companies in the same industry.
RDFN has a debt to FCF ratio of 24.25. This is a negative value and a sign of low solvency as RDFN would need 24.25 years to pay back of all of its debts.
RDFN's Debt to FCF ratio of 24.25 is fine compared to the rest of the industry. RDFN outperforms 67.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 24.25
Altman-Z -0.12
ROIC/WACCN/A
WACC7.21%
RDFN Yearly LT Debt VS Equity VS FCFRDFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.16 indicates that RDFN should not have too much problems paying its short term obligations.
RDFN has a Current ratio (1.16) which is in line with its industry peers.
RDFN has a Quick Ratio of 1.16. This is a normal value and indicates that RDFN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, RDFN is in line with its industry, outperforming 44.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
RDFN Yearly Current Assets VS Current LiabilitesRDFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for RDFN have decreased strongly by -28.57% in the last year.
RDFN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.10%.
Measured over the past years, RDFN shows a small growth in Revenue. The Revenue has been growing by 5.99% on average per year.
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.07%
Revenue 1Y (TTM)5.1%
Revenue growth 3Y-18.45%
Revenue growth 5Y5.99%
Sales Q2Q%-1.97%

3.2 Future

Based on estimates for the next years, RDFN will show a very strong growth in Earnings Per Share. The EPS will grow by 23.55% on average per year.
RDFN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.07% yearly.
EPS Next Y20.09%
EPS Next 2Y23.34%
EPS Next 3Y18.45%
EPS Next 5Y23.55%
Revenue Next Year-2.73%
Revenue Next 2Y1.22%
Revenue Next 3Y4.9%
Revenue Next 5Y10.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDFN Yearly Revenue VS EstimatesRDFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
RDFN Yearly EPS VS EstimatesRDFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDFN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDFN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDFN Price Earnings VS Forward Price EarningsRDFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, RDFN is valued a bit cheaper than the industry average as 72.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.23
EV/EBITDA N/A
RDFN Per share dataRDFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as RDFN's earnings are expected to grow with 18.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.34%
EPS Next 3Y18.45%

More info and screens

0

5. Dividend

5.1 Amount

RDFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REDFIN CORP

NASDAQ:RDFN (6/30/2025, 8:00:01 PM)

After market: 11.2994 +0.11 (+0.98%)

11.19

-0.04 (-0.36%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners67.33%
Inst Owner Change-0.27%
Ins Owners3.96%
Ins Owner Change-261.25%
Market Cap1.43B
Analysts54.44
Price Target9.75 (-12.87%)
Short Float %22.32%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-0.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.34%
Min EPS beat(2)-18.99%
Max EPS beat(2)-3.68%
EPS beat(4)1
Avg EPS beat(4)-10.97%
Min EPS beat(4)-35.52%
Max EPS beat(4)14.32%
EPS beat(8)5
Avg EPS beat(8)1%
EPS beat(12)7
Avg EPS beat(12)0.1%
EPS beat(16)10
Avg EPS beat(16)2.61%
Revenue beat(2)0
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-1.71%
Min Revenue beat(4)-2.91%
Max Revenue beat(4)-0.75%
Revenue beat(8)1
Avg Revenue beat(8)-1.6%
Revenue beat(12)3
Avg Revenue beat(12)-8.33%
Revenue beat(16)5
Avg Revenue beat(16)-9.65%
PT rev (1m)0%
PT rev (3m)1.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.14%
EPS NY rev (1m)0.83%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.38
P/FCF 35.23
P/OCF 27.79
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.53
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)0.32
FCFY2.84%
OCF(TTM)0.4
OCFY3.6%
SpS8.11
BVpS-1.23
TBVpS-5.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.78%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.05%
FCFM 3.92%
ROA(3y)-16.08%
ROA(5y)-11.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.46%
GM growth 5Y13.57%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 24.25
Debt/EBITDA N/A
Cap/Depr 29.68%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z -0.12
F-Score6
WACC7.21%
ROIC/WACCN/A
Cap/Depr(3y)26.19%
Cap/Depr(5y)47.61%
Cap/Sales(3y)1.08%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.07%
EPS Next Y20.09%
EPS Next 2Y23.34%
EPS Next 3Y18.45%
EPS Next 5Y23.55%
Revenue 1Y (TTM)5.1%
Revenue growth 3Y-18.45%
Revenue growth 5Y5.99%
Sales Q2Q%-1.97%
Revenue Next Year-2.73%
Revenue Next 2Y1.22%
Revenue Next 3Y4.9%
Revenue Next 5Y10.07%
EBIT growth 1Y18.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.4%
EBIT Next 3Y33.68%
EBIT Next 5Y26.72%
FCF growth 1Y241.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y536.5%
OCF growth 3YN/A
OCF growth 5YN/A